{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T22:24:49Z","timestamp":1792016689074,"version":"4.4.0"},"reference-count":232,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2019,5,7]],"date-time":"2019-05-07T00:00:00Z","timestamp":1557187200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000009","name":"Foundation for the National Institutes of Health","doi-asserted-by":"publisher","award":["P01NS092525"],"award-info":[{"award-number":["P01NS092525"]}],"id":[{"id":"10.13039\/100000009","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000009","name":"Foundation for the National Institutes of Health","doi-asserted-by":"publisher","award":["R01AG055523"],"award-info":[{"award-number":["R01AG055523"]}],"id":[{"id":"10.13039\/100000009","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000957","name":"Alzheimer\u2019s Association","doi-asserted-by":"publisher","award":["DSAD-15-363207"],"award-info":[{"award-number":["DSAD-15-363207"]}],"id":[{"id":"10.13039\/100000957","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007625","name":"Cure Alzheimer\u2019s Fund","doi-asserted-by":"publisher","award":["2018-1301"],"award-info":[{"award-number":["2018-1301"]}],"id":[{"id":"10.13039\/100007625","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Neurosci."],"DOI":"10.3389\/fnins.2019.00446","type":"journal-article","created":{"date-parts":[[2019,5,7]],"date-time":"2019-05-07T00:44:16Z","timestamp":1557189856000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":162,"title":["Exploring the Pathogenesis of Alzheimer Disease in Basal Forebrain Cholinergic Neurons: Converging Insights From Alternative Hypotheses"],"prefix":"10.3389","volume":"13","author":[{"given":"Xu-Qiao","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William C.","family":"Mobley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2019,5,7]]},"reference":[{"key":"B1","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1007\/s12272-013-0036-3","article-title":"A review on cholinesterase inhibitors for Alzheimer\u2019s disease.","volume":"36","author":"Anand","year":"2013","journal-title":"Arch. Pharm. Res."},{"key":"B2","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1016\/0024-3205(64)90161-4","article-title":"Demonstration and mapping out of nigro-neostriatal dopamine neurons.","volume":"3","author":"Anden","year":"1964","journal-title":"Life Sci."},{"key":"B3","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1111\/j.1748-1716.1966.tb03317.x","article-title":"A quantitative study on the nigro-neostriatal dopamine neuron system in the rat.","volume":"67","author":"Anden","year":"1966","journal-title":"Acta Physiol. Scand."},{"key":"B4","doi-asserted-by":"crossref","first-page":"3738","DOI":"10.1093\/brain\/awt273","article-title":"Cell number changes in Alzheimer\u2019s disease relate to dementia, not to plaques and tangles.","volume":"136","author":"Andrade-Moraes","year":"2013","journal-title":"Brain"},{"key":"B5","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1038\/nrg.2016.154","article-title":"Down syndrome and the complexity of genome dosage imbalance.","volume":"18","author":"Antonarakis","year":"2017","journal-title":"Nat. Rev. Genet."},{"key":"B6","first-page":"419","article-title":"Alzheimer disease.","volume":"22","author":"Apostolova","year":"2016","journal-title":"Continuum"},{"key":"B7","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1002\/ana.410100602","article-title":"A unifying hypothesis for the cause of amyotrophic lateral sclerosis, parkinsonism, and Alzheimer disease.","volume":"10","author":"Appel","year":"1981","journal-title":"Ann. Neurol."},{"key":"B8","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1212\/WNL.42.3.631","article-title":"Neurofibrillary tangles but not senile plaques parallel duration and severity of Alzheimer\u2019s disease.","volume":"42","author":"Arriagada","year":"1992","journal-title":"Neurology"},{"key":"B9","doi-asserted-by":"publisher","first-page":"9115","DOI":"10.1523\/jneurosci.2361-07.2007","article-title":"Immunotherapy targeting pathological tau conformers in a tangle mouse model reduces brain pathology with associated functional improvements.","volume":"27","author":"Asuni","year":"2007","journal-title":"J. Neurosci."},{"key":"B10","doi-asserted-by":"publisher","first-page":"1339","DOI":"10.1126\/science.2897715","article-title":"Expression of the beta-nerve growth factor gene in hippocampal neurons.","volume":"240","author":"Ayer-Lelievre","year":"1988","journal-title":"Science"},{"key":"B11","doi-asserted-by":"publisher","first-page":"1722","DOI":"10.1093\/brain\/awv024","article-title":"Neuronal amyloid-beta accumulation within cholinergic basal forebrain in ageing and Alzheimer\u2019s disease.","volume":"138","author":"Baker-Nigh","year":"2015","journal-title":"Brain"},{"key":"B12","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1007\/bf00692056","article-title":"Neuronal loss, neurofibrillary tangles and granulovacuolar degeneration in the hippocampus with ageing and dementia. A quantitative study.","volume":"37","author":"Ball","year":"1977","journal-title":"Acta Neuropathol."},{"key":"B13","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1007\/bf00690970","article-title":"Topographic distribution of neurofibrillary tangles and granulovacuolar degeneration in hippocampal cortex of aging and demented patients. A quantitative study.","volume":"42","author":"Ball","year":"1978","journal-title":"Acta Neuropathol."},{"key":"B14","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1016\/S1474-4422(16)00063-6","article-title":"Dementia in Down\u2019s syndrome.","volume":"15","author":"Ballard","year":"2016","journal-title":"Lancet Neurol."},{"key":"B15","doi-asserted-by":"publisher","first-page":"1199","DOI":"10.1016\/j.neuron.2016.09.006","article-title":"Basal forebrain cholinergic circuits and signaling in cognition and cognitive decline.","volume":"91","author":"Ballinger","year":"2016","journal-title":"Neuron"},{"key":"B16","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1126\/science.7046051","article-title":"The cholinergic hypothesis of geriatric memory dysfunction.","volume":"217","author":"Bartus","year":"1982","journal-title":"Science"},{"key":"B17","article-title":"Autosomal-dominant Alzheimer\u2019s disease: a review and proposal for the prevention of Alzheimer\u2019s disease.","volume":"3","author":"Bateman","year":"2011","journal-title":"Alzheimers Res. Ther."},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0152471","article-title":"An anti-beta-amyloid vaccine for treating cognitive deficits in a mouse model of down syndrome.","volume":"11","author":"Belichenko","year":"2016","journal-title":"PLoS One"},{"key":"B19","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1083\/jcb.136.2.375","article-title":"NGF and neurotrophin-3 both activate TrkA on sympathetic neurons but differentially regulate survival and neuritogenesis.","volume":"136","author":"Belliveau","year":"1997","journal-title":"J. Cell Biol."},{"key":"B20","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1016\/s0028-3908(99)00137-9","article-title":"The concept of transmitter receptors: 100 years on.","volume":"39","author":"Bennett","year":"2000","journal-title":"Neuropharmacology"},{"key":"B21","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1093\/emboj\/18.3.616","article-title":"Biochemical and functional interactions between the neurotrophin receptors trk and p75NTR.","volume":"18","author":"Bibel","year":"1999","journal-title":"EMBO J."},{"key":"B22","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1001\/archneur.1995.00540250089017","article-title":"Neocortical neurofibrillary tangles correlate with dementia severity in Alzheimer\u2019s disease.","volume":"52","author":"Bierer","year":"1995","journal-title":"Arch. Neurol."},{"key":"B23","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/0006-8993(75)90061-x","article-title":"Short- and long-term effects of nerve growth factor on the sympathetic nervous system in the adult mouse.","volume":"94","author":"Bjerre","year":"1975","journal-title":"Brain Res."},{"key":"B24","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1113\/jphysiol.1942.sp003988","article-title":"The activity of l(-)-dopa decarboxylase.","volume":"101","author":"Blaschko","year":"1942","journal-title":"J. Physiol."},{"key":"B25","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1006\/exnr.1997.6443","article-title":"Decreased TrkA gene expression in cholinergic neurons of the striatum and basal forebrain of patients with Alzheimer\u2019s disease.","volume":"145","author":"Boissiere","year":"1997","journal-title":"Exp. Neurol."},{"key":"B26","doi-asserted-by":"publisher","first-page":"13033","DOI":"10.1523\/jneurosci.2364-14.2014","article-title":"The role of p75NTR in cholinergic basal forebrain structure and function.","volume":"34","author":"Boskovic","year":"2014","journal-title":"J. Neurosci."},{"key":"B27","doi-asserted-by":"crossref","DOI":"10.1038\/s41398-018-0248-x","article-title":"Cholinergic basal forebrain neurons regulate fear extinction consolidation through p75 neurotrophin receptor signaling.","volume":"8","author":"Boskovic","year":"2018","journal-title":"Transl. Psychiatry"},{"key":"B28","doi-asserted-by":"crossref","DOI":"10.12688\/f1000research.8434.1","article-title":"Recent advances in understanding neurotrophin signaling.","volume":"5","author":"Bothwell","year":"2016","journal-title":"F1000Res."},{"key":"B29","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1111\/j.1471-4159.2011.07337.x","article-title":"Passive immunization targeting pathological phospho-tau protein in a mouse model reduces functional decline and clears tau aggregates from the brain.","volume":"118","author":"Boutajangout","year":"2011","journal-title":"J. Neurochem."},{"key":"B30","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1007\/bf00308809","article-title":"Neuropathological stageing of Alzheimer-related changes.","volume":"82","author":"Braak","year":"1991","journal-title":"Acta Neuropathol."},{"key":"B31","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1113\/jphysiol.1936.sp003414","article-title":"Reactions of the normal mammalian muscle to acetylcholine and to eserine.","volume":"87","author":"Brown","year":"1936","journal-title":"J. Physiol."},{"key":"B32","doi-asserted-by":"publisher","first-page":"8009","DOI":"10.1523\/jneurosci.1508-04.2004","article-title":"Long-lasting rescue of age-associated deficits in cognition and the CNS cholinergic phenotype by a partial agonist peptidomimetic ligand of TrkA.","volume":"24","author":"Bruno","year":"2004","journal-title":"J. Neurosci."},{"key":"B33","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1097\/nen.0b013e3181aed9e6","article-title":"Amyloid beta-induced nerve growth factor dysmetabolism in Alzheimer disease.","volume":"68","author":"Bruno","year":"2009","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"B34","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/B978-0-12-802395-2.00023-7","article-title":"Alzheimer disease.","volume":"145","author":"Calderon-Garciduenas","year":"2017","journal-title":"Handb. Clin. Neurol."},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1126\/science.127.3296.471","article-title":"On the presence of 3-hydroxytyramine in brain.","volume":"127","author":"Carlsson","year":"1958","journal-title":"Science"},{"key":"B36","doi-asserted-by":"publisher","first-page":"804","DOI":"10.1007\/s00415-016-8308-8","article-title":"Alzheimer\u2019s disease in people with Down\u2019s syndrome: the prospects for and the challenges of developing preventative treatments.","volume":"264","author":"Castro","year":"2017","journal-title":"J. Neurol."},{"key":"B37","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1038\/nrn1078","article-title":"Neurotrophins and their receptors: a convergence point for many signalling pathways.","volume":"4","author":"Chao","year":"2003","journal-title":"Nat. Rev. Neurosci."},{"key":"B38","doi-asserted-by":"publisher","first-page":"7288","DOI":"10.1523\/jneurosci.17-19-07288.1997","article-title":"Disruption of a single allele of the nerve growth factor gene results in atrophy of basal forebrain cholinergic neurons and memory deficits.","volume":"17","author":"Chen","year":"1997","journal-title":"J. Neurosci."},{"key":"B39","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.freeradbiomed.2017.10.341","article-title":"Dysregulation of neurotrophin signaling in the pathogenesis of Alzheimer disease and of Alzheimer disease in Down syndrome.","volume":"114","author":"Chen","year":"2018","journal-title":"Free Radic. Biol. Med."},{"key":"B40","doi-asserted-by":"crossref","first-page":"S567","DOI":"10.3233\/JAD-179941","article-title":"The amyloid-beta oligomer hypothesis: beginning of the third decade.","volume":"64","author":"Cline","year":"2018","journal-title":"J. Alzheimers Dis."},{"key":"B41","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1016\/s0896-6273(03)00288-5","article-title":"Lesions of the Basal forebrain cholinergic system impair task acquisition and abolish cortical plasticity associated with motor skill learning.","volume":"38","author":"Conner","year":"2003","journal-title":"Neuron"},{"key":"B42","doi-asserted-by":"publisher","first-page":"10439","DOI":"10.1073\/pnas.181219298","article-title":"Failed retrograde transport of NGF in a mouse model of Down\u2019s syndrome: reversal of cholinergic neurodegenerative phenotypes following NGF infusion.","volume":"98","author":"Cooper","year":"2001","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"B43","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.ejphar.2017.05.057","article-title":"The underexplored question of beta-amyloid monomers.","volume":"817","author":"Copani","year":"2017","journal-title":"Eur. J. Pharmacol."},{"key":"B44","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a020669","article-title":"Neuronal signaling through endocytosis.","volume":"6","author":"Cosker","year":"2014","journal-title":"Cold Spring Harb. Perspect. Biol."},{"key":"B45","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1056\/nejm196902132800701","article-title":"Modification of Parkinsonism\u2013chronic treatment with L-dopa.","volume":"280","author":"Cotzias","year":"1969","journal-title":"N. Engl. J. Med."},{"key":"B46","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1093\/jnen\/64.4.263","article-title":"The role of nerve growth factor receptors in cholinergic basal forebrain degeneration in prodromal Alzheimer disease.","volume":"64","author":"Counts","year":"2005","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"B47","doi-asserted-by":"publisher","first-page":"1184","DOI":"10.1126\/science.6338589","article-title":"Alzheimer\u2019s disease: a disorder of cortical cholinergic innervation.","volume":"219","author":"Coyle","year":"1983","journal-title":"Science"},{"key":"B48","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1016\/0092-8674(94)90378-6","article-title":"Mice lacking nerve growth factor display perinatal loss of sensory and sympathetic neurons yet develop basal forebrain cholinergic neurons.","volume":"76","author":"Crowley","year":"1994","journal-title":"Cell"},{"key":"B49","doi-asserted-by":"publisher","first-page":"2540","DOI":"10.1523\/jneurosci.13-06-02540.1993","article-title":"Detection of NGF-like activity in human brain tissue: increased levels in Alzheimer\u2019s disease.","volume":"13","author":"Crutcher","year":"1993","journal-title":"J. Neurosci."},{"key":"B50","doi-asserted-by":"publisher","first-page":"13666","DOI":"10.1073\/pnas.0706192104","article-title":"One at a time, live tracking of NGF axonal transport using quantum dots.","volume":"104","author":"Cui","year":"2007","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"B51","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.trci.2018.03.009","article-title":"Alzheimer\u2019s disease drug development pipeline: 2018.","volume":"4","author":"Cummings","year":"2018","journal-title":"Alzheimers Dement."},{"key":"B52","first-page":"231","article-title":"Evidence for the existence of monoamine-containing neurons in the central nervous system. I. Demonstration of monoamines in the cell bodies of brain stem neurons.","volume":"232","author":"Dahlstroem","year":"1964","journal-title":"Acta Physiol. Scand. Suppl."},{"key":"B53","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1113\/jphysiol.1936.sp003371","article-title":"Release of acetylcholine at voluntary motor nerve endings.","volume":"86","author":"Dale","year":"1936","journal-title":"J. Physiol."},{"key":"B54","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1016\/s0197-4580(01)00245-7","article-title":"Reduced effectiveness of Abeta1-42 immunization in APP transgenic mice with significant amyloid deposition.","volume":"22","author":"Das","year":"2001","journal-title":"Neurobiol. Aging"},{"key":"B55","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1016\/0896-6273(93)90069-4","article-title":"p75-deficient trigeminal sensory neurons have an altered response to NGF but not to other neurotrophins.","volume":"11","author":"Davies","year":"1993","journal-title":"Neuron"},{"key":"B56","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1016\/0006-8993(79)90336-6","article-title":"Neurotransmitter-related enzymes in senile dementia of the Alzheimer type.","volume":"171","author":"Davies","year":"1979","journal-title":"Brain Res."},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1016\/s0140-6736(76)91936-x","article-title":"Selective loss of central cholinergic neurons in Alzheimer\u2019s disease.","volume":"2","author":"Davies","year":"1976","journal-title":"Lancet"},{"key":"B58","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1001\/jama.281.15.1401","article-title":"Cholinergic markers in elderly patients with early signs of Alzheimer disease.","volume":"281","author":"Davis","year":"1999","journal-title":"JAMA"},{"key":"B59","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1006\/exnr.1997.6448","article-title":"Hyperplastic changes within the leptomeninges of the rat and monkey in response to chronic intracerebroventricular infusion of nerve growth factor.","volume":"145","author":"Day-Lollini","year":"1997","journal-title":"Exp. Neurol."},{"key":"B60","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1007\/s40266-015-0273-x","article-title":"The use of cholinesterase inhibitors across all stages of Alzheimer\u2019s disease.","volume":"32","author":"Deardorff","year":"2015","journal-title":"Drugs Aging"},{"key":"B61","doi-asserted-by":"publisher","first-page":"4067","DOI":"10.1073\/pnas.96.7.4067","article-title":"A nerve growth factor mimetic TrkA antagonist causes withdrawal of cortical cholinergic boutons in the adult rat.","volume":"96","author":"Debeir","year":"1999","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"B62","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1016\/j.neuron.2006.08.018","article-title":"Rab5 and Rab7 control endocytic sorting along the axonal retrograde transport pathway.","volume":"52","author":"Deinhardt","year":"2006","journal-title":"Neuron"},{"key":"B63","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1002\/ana.410270502","article-title":"Synapse loss in frontal cortex biopsies in Alzheimer\u2019s disease: correlation with cognitive severity.","volume":"27","author":"Dekosky","year":"1990","journal-title":"Ann. Neurol."},{"key":"B64","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/S0896-6273(03)00397-0","article-title":"NGF signaling in sensory neurons: evidence that early endosomes carry NGF retrograde signals.","volume":"39","author":"Delcroix","year":"2003","journal-title":"Neuron"},{"key":"B65","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1126\/science.174.4011.788","article-title":"The cholinergic synapse and the site of memory.","volume":"174","author":"Deutsch","year":"1971","journal-title":"Science"},{"key":"B66","doi-asserted-by":"publisher","first-page":"459","DOI":"10.3233\/jad-160836","article-title":"Down syndrome, partial trisomy 21, and absence of Alzheimer\u2019s disease: the role of APP.","volume":"56","author":"Doran","year":"2017","journal-title":"J. Alzheimers Dis."},{"key":"B67","doi-asserted-by":"publisher","first-page":"952","DOI":"10.2174\/1567205013666160314150501","article-title":"Molecular basis of familial and sporadic Alzheimer\u2019s disease.","volume":"13","author":"Dorszewska","year":"2016","journal-title":"Curr. Alzheimer Res."},{"key":"B68","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1001\/archneur.1974.00490320001001","article-title":"Human memory and the cholinergic system. A relationship to aging?","volume":"30","author":"Drachman","year":"1974","journal-title":"Arch. Neurol."},{"key":"B69","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1007\/BF01485901","article-title":"[Distribution of noradrenaline and dopamine (3-hydroxytyramine) in the human brain and their behavior in diseases of the extrapyramidal system].","volume":"38","author":"Ehringer","year":"1960","journal-title":"Klin. Wochenschr."},{"key":"B70","doi-asserted-by":"publisher","first-page":"951","DOI":"10.3233\/jad-2011-111517","article-title":"Peripheral administration of antisense oligonucleotides targeting the amyloid-beta protein precursor reverses AbetaPP and LRP-1 overexpression in the aged SAMP8 mouse brain.","volume":"28","author":"Erickson","year":"2012","journal-title":"J. Alzheimers Dis."},{"key":"B71","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1159\/000017069","article-title":"Intracerebroventricular infusion of nerve growth factor in three patients with Alzheimer\u2019s disease.","volume":"9","author":"Eriksdotter Jonhagen","year":"1998","journal-title":"Dement. Geriatr. Cogn. Disord."},{"key":"B72","doi-asserted-by":"crossref","DOI":"10.1186\/s13195-016-0195-9","article-title":"Targeted delivery of nerve growth factor to the cholinergic basal forebrain of Alzheimer\u2019s disease patients: application of a second-generation encapsulated cell biodelivery device.","volume":"8","author":"Eyjolfsdottir","year":"2016","journal-title":"Alzheimers Res. Ther."},{"key":"B73","doi-asserted-by":"publisher","first-page":"7644","DOI":"10.1523\/jneurosci.17-20-07644.1997","article-title":"A role for TrkA during maturation of striatal and basal forebrain cholinergic neurons in vivo.","volume":"17","author":"Fagan","year":"1997","journal-title":"J. Neurosci."},{"key":"B74","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/j.parkreldis.2017.07.020","article-title":"The 200-year journey of Parkinson disease: reflecting on the past and looking towards the future.","volume":"46","author":"Fahn","year":"2018","journal-title":"Parkinsonism Relat. Disord."},{"key":"B75","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/s0169-328x(96)00193-3","article-title":"Nerve growth factor mRNA and protein levels measured in the same tissue from normal and Alzheimer\u2019s disease parietal cortex.","volume":"42","author":"Fahnestock","year":"1996","journal-title":"Brain Res. Mol. Brain Res."},{"key":"B76","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.3233\/jad-131883","article-title":"Central and peripheral administration of antisense oligonucleotide targeting amyloid-beta protein precursor improves learning and memory and reduces neuroinflammatory cytokines in Tg2576 (AbetaPPswe) mice.","volume":"40","author":"Farr","year":"2014","journal-title":"J. Alzheimers Dis."},{"key":"B77","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1113\/jphysiol.1934.sp003137","article-title":"The chemical transmitter at synapses in a sympathetic ganglion.","volume":"81","author":"Feldberg","year":"1934","journal-title":"J. Physiol."},{"key":"B78","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/s0891-0618(96)00171-8","article-title":"NGF prevents further atrophy of cholinergic cells of the nucleus basalis due to cortical infarction in adult post-hypothyroid rats but does not restore cell size compared to euthyroid [correction of euthroid] rats.","volume":"12","author":"Figueiredo","year":"1996","journal-title":"J. Chem. Neuroanat."},{"key":"B79","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1007\/bf00337069","article-title":"Evidence for the existence of monoamine neurons in the central nervous system. 3. the monoamine nerve terminal.","volume":"65","author":"Fuxe","year":"","journal-title":"Z. Zellforsch. Mikrosk. Anat."},{"key":"B80","article-title":"Evidence for the existence of monoamine neurons in the central nervous system. IV. Distribution of monoamine nerve terminals in the central nervous system.","volume":"247","author":"Fuxe","year":"","journal-title":"Acta Physiol. Scand. Suppl."},{"key":"B81","doi-asserted-by":"publisher","first-page":"1495","DOI":"10.1212\/01.wnl.0000063311.58879.01","article-title":"Tangle and neuron numbers, but not amyloid load, predict cognitive status in Alzheimer\u2019s disease.","volume":"60","author":"Giannakopoulos","year":"2003","journal-title":"Neurology"},{"key":"B82","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1111\/j.1471-4159.2006.03764.x","article-title":"Down regulation of trk but not p75NTR gene expression in single cholinergic basal forebrain neurons mark the progression of Alzheimer\u2019s disease.","volume":"97","author":"Ginsberg","year":"2006","journal-title":"J. Neurochem."},{"key":"B83","doi-asserted-by":"crossref","first-page":"10582","DOI":"10.1523\/JNEUROSCI.1736-09.2009","article-title":"Beta-amyloid monomers are neuroprotective.","volume":"29","author":"Giuffrida","year":"2009","journal-title":"J. Neurosci."},{"key":"B84","doi-asserted-by":"publisher","DOI":"10.3389\/fncel.2015.00297","article-title":"Monomeric ss-amyloid interacts with type-1 insulin-like growth factor receptors to provide energy supply to neurons.","volume":"9","author":"Giuffrida","year":"2015","journal-title":"Front. Cell. Neurosci."},{"key":"B85","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/0165-3806(83)90107-4","article-title":"NGF-mediated increase of choline acetyltransferase (ChAT) in the neonatal rat forebrain: evidence for a physiological role of NGF in the brain?","volume":"285","author":"Gnahn","year":"1983","journal-title":"Brain Res."},{"key":"B86","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/0169-328x(89)90011-9","article-title":"Nerve growth factor receptor mRNA distribution in human brain: normal levels in basal forebrain in Alzheimer\u2019s disease.","volume":"5","author":"Goedert","year":"1989","journal-title":"Brain Res. Mol. Brain Res."},{"key":"B87","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1002\/ana.410410106","article-title":"Neuronal loss correlates with but exceeds neurofibrillary tangles in Alzheimer\u2019s disease.","volume":"41","author":"Gomez-Isla","year":"1997","journal-title":"Ann. Neurol."},{"key":"B88","doi-asserted-by":"publisher","first-page":"4491","DOI":"10.1523\/jneurosci.16-14-04491.1996","article-title":"Profound loss of layer II entorhinal cortex neurons occurs in very mild Alzheimer\u2019s disease.","volume":"16","author":"Gomez-Isla","year":"1996","journal-title":"J. Neurosci."},{"key":"B89","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1515\/REVNEURO.1998.9.1.31","article-title":"A non-invasive system for delivering neural growth factors across the blood-brain barrier: a review.","volume":"9","author":"Granholm","year":"1998","journal-title":"Rev. Neurosci."},{"key":"B90","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/0006-8993(89)90112-1","article-title":"Nerve growth factor (NGF) reverses axotomy-induced decreases in choline acetyltransferase, NGF receptor and size of medial septum cholinergic neurons.","volume":"505","author":"Hagg","year":"1989","journal-title":"Brain Res."},{"key":"B91","doi-asserted-by":"publisher","first-page":"1155","DOI":"10.1016\/j.cell.2015.07.057","article-title":"Central cholinergic neurons are rapidly recruited by reinforcement feedback.","volume":"162","author":"Hangya","year":"2015","journal-title":"Cell"},{"key":"B92","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1038\/nrn3253","article-title":"Long-distance retrograde neurotrophic factor signalling in neurons.","volume":"14","author":"Harrington","year":"2013","journal-title":"Nat. Rev. Neurosci."},{"key":"B93","doi-asserted-by":"publisher","first-page":"2155","DOI":"10.1523\/jneurosci.06-08-02155.1986","article-title":"Nerve growth factor promotes survival of septal cholinergic neurons after fimbrial transections.","volume":"6","author":"Hefti","year":"1986","journal-title":"J. Neurosci."},{"key":"B94","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/0306-4522(85)90163-0","article-title":"Nerve growth factor increases choline acetyltransferase but not survival or fiber outgrowth of cultured fetal septal cholinergic neurons.","volume":"14","author":"Hefti","year":"1985","journal-title":"Neuroscience"},{"key":"B95","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1111\/j.1365-2990.1994.tb00951.x","article-title":"Hirano bodies and related neuronal inclusions.","volume":"20","author":"Hirano","year":"1994","journal-title":"Neuropathol. Appl. Neurobiol."},{"key":"B96","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1097\/yco.0000000000000307","article-title":"Cognitive decline and dementia in Down syndrome.","volume":"30","author":"Hithersay","year":"2017","journal-title":"Curr. Opin. Psychiatry"},{"key":"B97","doi-asserted-by":"publisher","DOI":"10.1001\/jamaneurol.2018.3616","article-title":"Association of dementia with mortality among adults with down syndrome older than 35 years.","author":"Hithersay","year":"2018","journal-title":"JAMA Neurol."},{"key":"B98","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1001\/archneur.57.6.846","article-title":"Region-specific neurotrophin imbalances in Alzheimer disease: decreased levels of brain-derived neurotrophic factor and increased levels of nerve growth factor in hippocampus and cortical areas.","volume":"57","author":"Hock","year":"2000","journal-title":"Arch. Neurol."},{"key":"B99","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/s0304-3940(98)00019-6","article-title":"Decreased trkA neurotrophin receptor expression in the parietal cortex of patients with Alzheimer\u2019s disease.","volume":"241","author":"Hock","year":"1998","journal-title":"Neurosci. Lett."},{"key":"B100","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1016\/s0896-6273(03)00294-0","article-title":"Antibodies against beta-amyloid slow cognitive decline in Alzheimer\u2019s disease.","volume":"38","author":"Hock","year":"2003","journal-title":"Neuron"},{"key":"B101","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1016\/j.jalz.2016.03.018","article-title":"Tau: from research to clinical development.","volume":"12","author":"Holtzman","year":"2016","journal-title":"Alzheimers Dement."},{"key":"B102","doi-asserted-by":"publisher","first-page":"1567","DOI":"10.1523\/jneurosci.15-02-01567.1995","article-title":"TrkA expression in the CNS: evidence for the existence of several novel NGF-responsive CNS neurons.","volume":"15","author":"Holtzman","year":"1995","journal-title":"J. Neurosci."},{"key":"B103","doi-asserted-by":"crossref","first-page":"2668","DOI":"10.1212\/WNL.43.12.2668","article-title":"Nerve growth factor reverses neuronal atrophy in a Down syndrome model of age-related neurodegeneration.","volume":"43","author":"Holtzman","year":"1993","journal-title":"Neurology"},{"key":"B104","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1016\/0896-6273(92)90184-f","article-title":"p140trk mRNA marks NGF-responsive forebrain neurons: evidence that trk gene expression is induced by NGF.","volume":"9","author":"Holtzman","year":"1992","journal-title":"Neuron"},{"key":"B105","doi-asserted-by":"publisher","first-page":"383","DOI":"10.2170\/physiolsci.sc008107","article-title":"Stimulation of the nucleus basalis of Meynert produces an increase in the extracellular release of nerve growth factor in the rat cerebral cortex.","volume":"57","author":"Hotta","year":"2007","journal-title":"J. Physiol. Sci."},{"key":"B106","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.conb.2005.01.010","article-title":"Long-distance retrograde neurotrophic signaling.","volume":"15","author":"Howe","year":"2005","journal-title":"Curr. Opin. Neurobiol."},{"key":"B107","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1016\/s0896-6273(01)00526-8","article-title":"NGF signaling from clathrin-coated vesicles: evidence that signaling endosomes serve as a platform for the Ras-MAPK pathway.","volume":"32","author":"Howe","year":"2001","journal-title":"Neuron"},{"key":"B108","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1146\/annurev.neuro.24.1.677","article-title":"Neurotrophins: roles in neuronal development and function.","volume":"24","author":"Huang","year":"2001","journal-title":"Annu. Rev. Neurosci."},{"key":"B109","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1016\/j.tips.2014.04.010","article-title":"Nerve growth factor metabolic dysfunction in Alzheimer\u2019s disease and Down syndrome.","volume":"35","author":"Iulita","year":"2014","journal-title":"Trends Pharmacol. Sci."},{"key":"B110","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1093\/brain\/awt372","article-title":"Nerve growth factor metabolic dysfunction in Down\u2019s syndrome brains.","volume":"137","author":"Iulita","year":"2014","journal-title":"Brain"},{"key":"B111","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1016\/0169-328x(94)90159-7","article-title":"NGF mRNA is not decreased in frontal cortex from Alzheimer\u2019s disease patients.","volume":"25","author":"Jette","year":"1994","journal-title":"Brain Res. Mol. Brain Res."},{"key":"B112","doi-asserted-by":"publisher","first-page":"1630","DOI":"10.1073\/pnas.0908953107","article-title":"Alzheimer\u2019s-related endosome dysfunction in Down syndrome is Abeta-independent but requires APP and is reversed by BACE-1 inhibition.","volume":"107","author":"Jiang","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"B113","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1016\/0092-8674(86)90619-7","article-title":"Expression and structure of the human NGF receptor.","volume":"47","author":"Johnson","year":"1986","journal-title":"Cell"},{"key":"B114","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1016\/s0006-8993(02)02623-9","article-title":"Selective lesion of cholinergic neurons in the medial septum by 192 IgG-saporin impairs learning in a delayed matching to position T-maze paradigm.","volume":"943","author":"Johnson","year":"2002","journal-title":"Brain Res."},{"key":"B115","doi-asserted-by":"publisher","first-page":"5392","DOI":"10.1073\/pnas.76.10.5392","article-title":"Evidence for a cholinergic projection to neocortex from neurons in basal forebrain.","volume":"76","author":"Johnston","year":"1979","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"B116","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2018.00025","article-title":"Reconsideration of amyloid hypothesis and tau hypothesis in Alzheimer\u2019s disease.","volume":"12","author":"Kametani","year":"2018","journal-title":"Front. Neurosci."},{"key":"B117","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1126\/science.1850549","article-title":"The trk proto-oncogene product: a signal transducing receptor for nerve growth factor.","volume":"252","author":"Kaplan","year":"1991","journal-title":"Science"},{"key":"B118","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.biopsych.2014.05.006","article-title":"Alzheimer\u2019s disease risk genes and mechanisms of disease pathogenesis.","volume":"77","author":"Karch","year":"2015","journal-title":"Biol. Psychiatry"},{"key":"B119","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1038\/mp.2015.97","article-title":"Evidence that the rab5 effector APPL1 mediates APP-betaCTF-induced dysfunction of endosomes in Down syndrome and Alzheimer\u2019s disease.","volume":"21","author":"Kim","year":"2016","journal-title":"Mol. Psychiatry"},{"key":"B120","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/j.trci.2018.06.014","article-title":"Inflammation as a central mechanism in Alzheimer\u2019s disease.","volume":"4","author":"Kinney","year":"2018","journal-title":"Alzheimers Dement."},{"key":"B121","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1001\/jama.271.13.985","article-title":"A 30-week randomized controlled trial of high-dose tacrine in patients with Alzheimer\u2019s disease. The Tacrine Study Group.","volume":"271","author":"Knapp","year":"1994","journal-title":"JAMA"},{"key":"B122","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.nlm.2016.06.001","article-title":"The role of basal forebrain cholinergic neurons in fear and extinction memory.","volume":"133","author":"Knox","year":"2016","journal-title":"Neurobiol. Learn. Mem."},{"key":"B123","doi-asserted-by":"publisher","first-page":"12031","DOI":"10.1073\/pnas.0813248106","article-title":"The genetic architecture of Down syndrome phenotypes revealed by high-resolution analysis of human segmental trisomies.","volume":"106","author":"Korbel","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"B124","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1002\/cne.903270305","article-title":"NGF receptor (p75)-immunoreactivity in the developing primate basal ganglia.","volume":"327","author":"Kordower","year":"1993","journal-title":"J. Comp. Neurol."},{"key":"B125","doi-asserted-by":"publisher","first-page":"1389","DOI":"10.1002\/j.1460-2075.1985.tb03791.x","article-title":"Levels of nerve growth factor and its mRNA in the central nervous system of the rat correlate with cholinergic innervation.","volume":"4","author":"Korsching","year":"1985","journal-title":"EMBO J."},{"key":"B126","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/0304-3940(86)90186-2","article-title":"Cholinergic denervation of the rat hippocampus by fimbrial transection leads to a transient accumulation of nerve growth factor (NGF) without change in mRNANGF content.","volume":"66","author":"Korsching","year":"1986","journal-title":"Neurosci. Lett."},{"key":"B127","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1016\/j.neuron.2010.08.018","article-title":"Modulation of gamma-secretase reduces beta-amyloid deposition in a transgenic mouse model of Alzheimer\u2019s disease.","volume":"67","author":"Kounnas","year":"2010","journal-title":"Neuron"},{"key":"B128","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1126\/science.3798108","article-title":"Nerve growth factor treatment after brain injury prevents neuronal death.","volume":"235","author":"Kromer","year":"1987","journal-title":"Science"},{"key":"B129","doi-asserted-by":"publisher","first-page":"1769","DOI":"10.1016\/s0196-9781(00)00339-9","article-title":"Site-directed antisense oligonucleotide decreases the expression of amyloid precursor protein and reverses deficits in learning and memory in aged SAMP8 mice.","volume":"21","author":"Kumar","year":"2000","journal-title":"Peptides"},{"key":"B130","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1124\/jpet.106.112102","article-title":"The experimental Alzheimer\u2019s disease drug posiphen [(+)-phenserine] lowers amyloid-beta peptide levels in cell culture and mice.","volume":"320","author":"Lahiri","year":"2007","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"B131","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1126\/science.3764415","article-title":"Nerve growth factor gene expression in the developing rat brain.","volume":"234","author":"Large","year":"1986","journal-title":"Science"},{"key":"B132","doi-asserted-by":"publisher","first-page":"1308","DOI":"10.1523\/jneurosci.16-04-01308.1996","article-title":"Potent human p140-TrkA agonists derived from an anti-receptor monoclonal antibody.","volume":"16","author":"Lesauteur","year":"1996","journal-title":"J. Neurosci."},{"key":"B133","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1002\/jez.1401160206","article-title":"Selective growth stimulating effects of mouse sarcoma on the sensory and sympathetic nervous system of the chick embryo.","volume":"116","author":"Levi-Montalcini","year":"1951","journal-title":"J. Exp. Zool."},{"key":"B134","doi-asserted-by":"publisher","first-page":"2888","DOI":"10.1523\/jneurosci.15-04-02888.1995","article-title":"Regulation of TrkA and ChAT expression in developing rat basal forebrain: evidence that both exogenous and endogenous NGF regulate differentiation of cholinergic neurons.","volume":"15","author":"Li","year":"1995","journal-title":"J. Neurosci."},{"key":"B135","doi-asserted-by":"publisher","first-page":"1375","DOI":"10.1091\/mbc.e06-08-0725","article-title":"Nerve growth factor-mediated neurite outgrowth via regulation of Rab5.","volume":"18","author":"Liu","year":"2007","journal-title":"Mol. Biol. Cell"},{"key":"B136","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1007\/BF01738910","article-title":"\u00dcber humorale \u00fcbertragbarkeit der herznervenwirkung. I. Mitteilung.","volume":"189","author":"Loewi","year":"1921","journal-title":"Pfl\u00fcgers Arch. Gesamte Physiol."},{"key":"B137","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1007\/bf01741946","article-title":"\u00dcber humorale \u00fcbertragbarkeit der herznerven-wirkung. X. Mitteilung. \u00dcber das schicksal des vagusstoffes.","volume":"214","author":"Loewi","year":"1926","journal-title":"Pfl\u00fcgers Arch. Ges. Physiol."},{"key":"B138","doi-asserted-by":"publisher","first-page":"894","DOI":"10.1136\/jnnp-2012-302589","article-title":"Posiphen as a candidate drug to lower CSF amyloid precursor protein, amyloid-beta peptide and tau levels: target engagement, tolerability and pharmacokinetics in humans.","volume":"83","author":"Maccecchini","year":"2012","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"B139","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1016\/S0140-6736(96)10203-8","article-title":"Auguste D and Alzheimer\u2019s disease.","volume":"349","author":"Maurer","year":"1997","journal-title":"Lancet"},{"key":"B140","doi-asserted-by":"publisher","first-page":"853","DOI":"10.3233\/jad-160488","article-title":"Inflammation, antiinflammatory agents, and Alzheimer\u2019s disease: the last 22 years.","volume":"54","author":"Mcgeer","year":"2016","journal-title":"J. Alzheimers Dis."},{"key":"B141","doi-asserted-by":"crossref","DOI":"10.3390\/ijms19041160","article-title":"An overview on the clinical development of tau-based therapeutics.","volume":"19","author":"Medina","year":"2018","journal-title":"Int. J. Mol. Sci."},{"key":"B142","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1097\/gim.0b013e3181b2e34c","article-title":"The 50th anniversary of the discovery of trisomy 21: the past, present, and future of research and treatment of Down syndrome.","volume":"11","author":"Megarbane","year":"2009","journal-title":"Genet. Med."},{"key":"B143","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1002\/ana.20100","article-title":"Cholinergic nucleus basalis tauopathy emerges early in the aging-MCI-AD continuum.","volume":"55","author":"Mesulam","year":"2004","journal-title":"Ann. Neurol."},{"key":"B144","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1002\/cne.902140206","article-title":"Cholinergic innervation of cortex by the basal forebrain: cytochemistry and cortical connections of the septal area, diagonal band nuclei, nucleus basalis (substantia innominata), and hypothalamus in the rhesus monkey.","volume":"214","author":"Mesulam","year":"1983","journal-title":"J. Comp. Neurol."},{"key":"B145","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1006\/dbio.1994.1021","article-title":"Nerve growth factor derived from terminals selectively increases the ratio of p75 to trkA NGF receptors on mature sympathetic neurons.","volume":"161","author":"Miller","year":"1994","journal-title":"Dev. Biol."},{"key":"B146","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1126\/science.2861660","article-title":"Choline acetyltransferase activity in striatum of neonatal rats increased by nerve growth factor.","volume":"229","author":"Mobley","year":"1985","journal-title":"Science"},{"key":"B147","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/0169-328x(86)90020-3","article-title":"Nerve growth factor increases choline acetyltransferase activity in developing basal forebrain neurons.","volume":"387","author":"Mobley","year":"1986","journal-title":"Brain Res."},{"key":"B148","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1006\/exnr.1997.6504","article-title":"Reduction in p140-TrkA receptor protein within the nucleus basalis and cortex in Alzheimer\u2019s disease.","volume":"146","author":"Mufson","year":"1997","journal-title":"Exp. Neurol."},{"key":"B149","doi-asserted-by":"publisher","first-page":"9810","DOI":"10.1073\/pnas.0703137104","article-title":"Liposomal vaccines with conformation-specific amyloid peptide antigens define immune response and efficacy in APP transgenic mice.","volume":"104","author":"Muhs","year":"2007","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"B150","doi-asserted-by":"publisher","first-page":"2409","DOI":"10.1523\/jneurosci.22-07-02409.2002","article-title":"Complete deletion of the neurotrophin receptor p75NTR leads to long-lasting increases in the number of basal forebrain cholinergic neurons.","volume":"22","author":"Naumann","year":"2002","journal-title":"J. Neurosci."},{"key":"B151","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/j.nbd.2015.02.022","article-title":"Increased cortical synaptic activation of TrkB and downstream signaling markers in a mouse model of Down Syndrome.","volume":"77","author":"Nosheny","year":"2015","journal-title":"Neurobiol. Dis."},{"key":"B152","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1212\/01.wnl.0000073623.84147.a8","article-title":"Subacute meningoencephalitis in a subset of patients with AD after Abeta42 immunization.","volume":"61","author":"Orgogozo","year":"2003","journal-title":"Neurology"},{"key":"B153","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1002\/ana.25410","article-title":"Amyloid-beta immunotherapy for Alzheimer\u2019s disease - is it now a long shot?","volume":"85","author":"Panza","year":"2019","journal-title":"Ann. Neurol"},{"key":"B154","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1111\/ejn.12090","article-title":"Diminished trkA receptor signaling reveals cholinergic-attentional vulnerability of aging.","volume":"37","author":"Parikh","year":"2013","journal-title":"Eur. J. Neurosci."},{"key":"B155","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1016\/j.devcel.2018.07.001","article-title":"Retrograde degenerative signaling mediated by the p75 neurotrophin receptor requires p150(glued) deacetylation by axonal HDAC1.","volume":"46","author":"Pathak","year":"2018","journal-title":"Dev. Cell"},{"key":"B156","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/j.molmed.2015.03.003","article-title":"Tau immunotherapy for Alzheimer\u2019s disease.","volume":"21","author":"Pedersen","year":"2015","journal-title":"Trends Mol. Med."},{"key":"B157","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1007\/s00401-012-1062-9","article-title":"Distinct patterns of APP processing in the CNS in autosomal-dominant and sporadic Alzheimer disease.","volume":"125","author":"Pera","year":"2013","journal-title":"Acta Neuropathol."},{"key":"B158","doi-asserted-by":"publisher","DOI":"10.1016\/s0140-6736(77)91780-9","article-title":"Necropsy evidence of central cholinergic deficits in senile dementia.","volume":"1","author":"Perry","year":"1977","journal-title":"Lancet"},{"key":"B159","doi-asserted-by":"publisher","first-page":"1457","DOI":"10.1136\/bmj.2.6150.1457","article-title":"Correlation of cholinergic abnormalities with senile plaques and mental test scores in senile dementia.","volume":"2","author":"Perry","year":"1978","journal-title":"Br. Med. J."},{"key":"B160","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1016\/0896-6273(91)90273-3","article-title":"BDNF mRNA is decreased in the hippocampus of individuals with Alzheimer\u2019s disease.","volume":"7","author":"Phillips","year":"1991","journal-title":"Neuron"},{"key":"B161","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1093\/brain\/88.1.181","article-title":"Influence of the substantia nigra on the catecholamine content of the striatum.","volume":"88","author":"Poirier","year":"1965","journal-title":"Brain"},{"key":"B162","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1002\/ana.410430316","article-title":"Molecular mapping of Alzheimer-type dementia in Down\u2019s syndrome.","volume":"43","author":"Prasher","year":"1998","journal-title":"Ann. Neurol."},{"key":"B163","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1146\/annurev.me.36.020185.002025","article-title":"Alzheimer\u2019s disease.","volume":"36","author":"Price","year":"1985","journal-title":"Annu. Rev. Med."},{"key":"B164","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1038\/325593a0","article-title":"Gene transfer and molecular cloning of the rat nerve growth factor receptor.","volume":"325","author":"Radeke","year":"1987","journal-title":"Nature"},{"key":"B165","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1016\/j.jalz.2013.09.004","article-title":"A phase1 study of stereotactic gene delivery of AAV2-NGF for Alzheimer\u2019s disease.","volume":"10","author":"Rafii","year":"2014","journal-title":"Alzheimers Dement."},{"key":"B166","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1001\/jamaneurol.2018.0233","article-title":"Adeno-associated viral vector (serotype 2)-nerve growth factor for patients with alzheimer disease: a randomized clinical trial.","volume":"75","author":"Rafii","year":"2018","journal-title":"JAMA Neurol."},{"key":"B167","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1016\/j.bcp.2013.12.024","article-title":"Alzheimer disease: epidemiology, diagnostic criteria, risk factors and biomarkers.","volume":"88","author":"Reitz","year":"2014","journal-title":"Biochem. Pharmacol."},{"key":"B168","doi-asserted-by":"publisher","first-page":"3991","DOI":"10.1523\/jneurosci.16-12-03991.1996","article-title":"Expression of NGF and NT3 mRNAs in hippocampal interneurons innervated by the GABAergic septohippocampal pathway.","volume":"16","author":"Rocamora","year":"1996","journal-title":"J. Neurosci."},{"key":"B169","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.neuron.2006.05.022","article-title":"Increased App expression in a mouse model of Down\u2019s syndrome disrupts NGF transport and causes cholinergic neuron degeneration.","volume":"51","author":"Salehi","year":"2006","journal-title":"Neuron"},{"key":"B170","article-title":"Posiphen treatment is able to reduce APP levels in Ts65Dn mouse model of Down syndrome","author":"Salehi","year":"2008","journal-title":"Proceedings of the Alzheimer\u2019s Association International Conference on Alzheimer\u2019s Disease"},{"key":"B171","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1006\/exnr.1999.7252","article-title":"P75 neurotrophin receptor in the nucleus basalis of meynert in relation to age, sex, and Alzheimer\u2019s disease.","volume":"161","author":"Salehi","year":"2000","journal-title":"Exp. Neurol."},{"key":"B172","author":"Sawa","year":"2018"},{"key":"B173","doi-asserted-by":"publisher","first-page":"10930","DOI":"10.1523\/jneurosci.2029-05.2005","article-title":"The small GTPase Rab7 controls the endosomal trafficking and neuritogenic signaling of the nerve growth factor receptor TrkA.","volume":"25","author":"Saxena","year":"2005","journal-title":"J. Neurosci."},{"key":"B174","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/0197-4580(90)90059-9","article-title":"Quantitative assessment of cortical synaptic density in Alzheimer\u2019s disease.","volume":"11","author":"Scheff","year":"1990","journal-title":"Neurobiol. Aging"},{"key":"B175","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1002\/ana.410330209","article-title":"Synapse loss in the temporal lobe in Alzheimer\u2019s disease.","volume":"33","author":"Scheff","year":"1993","journal-title":"Ann. Neurol."},{"key":"B176","doi-asserted-by":"publisher","first-page":"1501","DOI":"10.1212\/01.wnl.0000260698.46517.8f","article-title":"Synaptic alterations in CA1 in mild Alzheimer disease and mild cognitive impairment.","volume":"68","author":"Scheff","year":"2007","journal-title":"Neurology"},{"key":"B177","doi-asserted-by":"publisher","first-page":"1372","DOI":"10.1016\/j.neurobiolaging.2005.09.012","article-title":"Hippocampal synaptic loss in early Alzheimer\u2019s disease and mild cognitive impairment.","volume":"27","author":"Scheff","year":"2006","journal-title":"Neurobiol. Aging"},{"key":"B178","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/S0140-6736(15)01124-1","article-title":"Alzheimer\u2019s disease.","volume":"388","author":"Scheltens","year":"2016","journal-title":"Lancet"},{"key":"B179","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1038\/22124","article-title":"Immunization with amyloid-beta attenuates Alzheimer-disease-like pathology in the PDAPP mouse.","volume":"400","author":"Schenk","year":"1999","journal-title":"Nature"},{"key":"B180","doi-asserted-by":"publisher","first-page":"1056","DOI":"10.1016\/j.neuron.2017.04.010","article-title":"Antisense oligonucleotides: translation from mouse models to human neurodegenerative diseases.","volume":"94","author":"Schoch","year":"2017","journal-title":"Neuron"},{"key":"B181","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1007\/s00018-014-1729-6","article-title":"Mechanisms of developmental neurite pruning.","volume":"72","author":"Schuldiner","year":"2015","journal-title":"Cell. Mol. Life Sci."},{"key":"B182","doi-asserted-by":"publisher","first-page":"6213","DOI":"10.1523\/jneurosci.15-09-06213.1995","article-title":"Nerve growth factor in Alzheimer\u2019s disease: increased levels throughout the brain coupled with declines in nucleus basalis.","volume":"15","author":"Scott","year":"1995","journal-title":"J. Neurosci."},{"key":"B183","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.mcn.2018.03.013","article-title":"Mechanisms of neurotrophin trafficking via Trk receptors.","volume":"91","author":"Scott-Solomon","year":"2018","journal-title":"Mol. Cell. Neurosci."},{"key":"B184","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/0006-8993(84)91338-6","article-title":"Specific retrograde transport of nerve growth factor (NGF) from neocortex to nucleus basalis in the rat.","volume":"300","author":"Seiler","year":"1984","journal-title":"Brain Res."},{"key":"B185","doi-asserted-by":"crossref","first-page":"595","DOI":"10.15252\/emmm.201606210","article-title":"The amyloid hypothesis of Alzheimer\u2019s disease at 25 years.","volume":"8","author":"Selkoe","year":"2016","journal-title":"EMBO Mol. Med."},{"key":"B186","doi-asserted-by":"publisher","first-page":"1185","DOI":"10.1046\/j.1471-4159.2000.741185.x","article-title":"Reduction in TrkA-immunoreactive neurons is not associated with an overexpression of galaninergic fibers within the nucleus basalis in Down\u2019s syndrome.","volume":"74","author":"Sendera","year":"2000","journal-title":"J. Neurochem."},{"key":"B187","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a006189","article-title":"Neuropathological alterations in Alzheimer disease.","volume":"1","author":"Serrano-Pozo","year":"","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"B188","doi-asserted-by":"publisher","first-page":"1373","DOI":"10.1016\/j.ajpath.2011.05.047","article-title":"Reactive glia not only associates with plaques but also parallels tangles in Alzheimer\u2019s disease.","volume":"179","author":"Serrano-Pozo","year":"","journal-title":"Am. J. Pathol."},{"key":"B189","doi-asserted-by":"publisher","author":"Servick","year":"2019","DOI":"10.1126\/science.aax4236"},{"key":"B190","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1038\/nature19323","article-title":"The antibody aducanumab reduces Abeta plaques in Alzheimer\u2019s disease.","volume":"537","author":"Sevigny","year":"2016","journal-title":"Nature"},{"key":"B191","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2017.00083","article-title":"Tau oligomers: cytotoxicity, propagation, and mitochondrial damage.","volume":"9","author":"Shafiei","year":"2017","journal-title":"Front. Aging Neurosci."},{"key":"B192","doi-asserted-by":"publisher","first-page":"2714","DOI":"10.1073\/pnas.83.8.2714","article-title":"Studies on the expression of the beta nerve growth factor (NGF) gene in the central nervous system: level and regional distribution of NGF mRNA suggest that NGF functions as a trophic factor for several distinct populations of neurons.","volume":"83","author":"Shelton","year":"1986","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"B193","doi-asserted-by":"publisher","DOI":"10.1038\/mtna.2015.15","article-title":"Intraventricular delivery of siRNA nanoparticles to the central nervous system.","volume":"4","author":"Shyam","year":"2015","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"B194","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/S0165-0173(00)00030-8","article-title":"Neurotrophic factors in Alzheimer\u2019s and Parkinson\u2019s disease brain.","volume":"33","author":"Siegel","year":"2000","journal-title":"Brain Res. Brain Res. Rev."},{"key":"B195","doi-asserted-by":"publisher","first-page":"1217","DOI":"10.1146\/annurev.neuro.24.1.1217","article-title":"Nerve growth factor signaling, neuroprotection, and neural repair.","volume":"24","author":"Sofroniew","year":"2001","journal-title":"Annu. Rev. Neurosci."},{"key":"B196","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2014.00114","article-title":"Immunotherapy for Alzheimer\u2019s disease: past, present and future.","volume":"6","author":"Spencer","year":"2014","journal-title":"Front. Aging Neurosci."},{"key":"B197","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1146\/annurev.ne.05.030182.001325","article-title":"The neuropsychology of human memory.","volume":"5","author":"Squire","year":"1982","journal-title":"Annu. Rev. Neurosci."},{"key":"B198","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.nlm.2018.05.009","article-title":"Disruption of medial septum and diagonal bands of Broca cholinergic projections to the ventral hippocampus disrupt auditory fear memory.","volume":"152","author":"Staib","year":"2018","journal-title":"Neurobiol. Learn. Mem."},{"key":"B199","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1016\/j.bbadis.2004.06.017","article-title":"Tau phosphorylation: physiological and pathological consequences.","volume":"1739","author":"Stoothoff","year":"2005","journal-title":"Biochim. Biophys. Acta"},{"key":"B200","doi-asserted-by":"publisher","first-page":"1241","DOI":"10.1056\/nejm198611133152001","article-title":"Oral tetrahydroaminoacridine in long-term treatment of senile dementia, Alzheimer type.","volume":"315","author":"Summers","year":"1986","journal-title":"N. Engl. J. Med."},{"key":"B201","doi-asserted-by":"crossref","DOI":"10.1016\/j.cell.2017.07.004","article-title":"Alzheimer\u2019s-causing mutations shift abeta length by destabilizing gamma-secretase-abetan interactions.","volume":"170","author":"Szaruga","year":"2017","journal-title":"Cell"},{"key":"B202","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.trci.2017.12.001","article-title":"Translational inhibition of APP by Posiphen: efficacy, pharmacodynamics, and pharmacokinetics in the APP\/PS1 mouse.","volume":"4","author":"Teich","year":"2018","journal-title":"Alzheimers Dement. Transl. Res. Clin. Interv."},{"key":"B203","doi-asserted-by":"publisher","first-page":"1791","DOI":"10.1212\/wnl.58.12.1791","article-title":"Phases of A beta-deposition in the human brain and its relevance for the development of AD.","volume":"58","author":"Thal","year":"2002","journal-title":"Neurology"},{"key":"B204","doi-asserted-by":"publisher","first-page":"29615","DOI":"10.1074\/jbc.r800019200","article-title":"Amyloid precursor protein trafficking, processing, and function.","volume":"283","author":"Thinakaran","year":"2008","journal-title":"J. Biol. Chem."},{"key":"B205","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.jocn.2015.12.032","article-title":"Professor alois Alzheimer (1864-1915): lest we forget.","volume":"31","author":"Toodayan","year":"2016","journal-title":"J. Clin. Neurosci."},{"key":"B206","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1038\/nm1239","article-title":"A phase 1 clinical trial of nerve growth factor gene therapy for Alzheimer disease.","volume":"11","author":"Tuszynski","year":"2005","journal-title":"Nat. Med."},{"key":"B207","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1001\/jamaneurol.2015.1807","article-title":"Nerve growth factor gene therapy: activation of neuronal responses in Alzheimer disease.","volume":"72","author":"Tuszynski","year":"2015","journal-title":"JAMA Neurol."},{"key":"B208","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1038\/gim.2015.117","article-title":"The genetic landscape of Alzheimer disease: clinical implications and perspectives.","volume":"18","author":"Van Cauwenberghe","year":"2016","journal-title":"Genet. Med."},{"key":"B209","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1016\/j.biopsych.2017.08.010","article-title":"Anti-amyloid-beta monoclonal antibodies for alzheimer\u2019s disease: pitfalls and promise.","volume":"83","author":"Van Dyck","year":"2018","journal-title":"Biol. Psychiatry"},{"key":"B210","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1083\/jcb.201407065","article-title":"Tau reduction prevents Abeta-induced axonal transport deficits by blocking activation of GSK3beta.","volume":"209","author":"Vossel","year":"2015","journal-title":"J. Cell Biol."},{"key":"B211","doi-asserted-by":"publisher","DOI":"10.1126\/science.1194653","article-title":"Tau reduction prevents Abeta-induced defects in axonal transport.","volume":"330","author":"Vossel","year":"2010","journal-title":"Science"},{"key":"B212","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1124\/jpet.117.240861","article-title":"Pharmacological and toxicological properties of the potent oral gamma-secretase modulator BPN-15606.","volume":"362","author":"Wagner","year":"2017","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"B213","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1111\/j.1742-4658.2010.07955.x","article-title":"The role of DYRK1A in neurodegenerative diseases.","volume":"278","author":"Wegiel","year":"2011","journal-title":"FEBS J."},{"key":"B214","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1002\/ana.410100203","article-title":"Alzheimer disease: evidence for selective loss of cholinergic neurons in the nucleus basalis.","volume":"10","author":"Whitehouse","year":"1981","journal-title":"Ann. Neurol."},{"key":"B215","doi-asserted-by":"publisher","first-page":"1237","DOI":"10.1126\/science.7058341","article-title":"Alzheimer\u2019s disease and senile dementia: loss of neurons in the basal forebrain.","volume":"215","author":"Whitehouse","year":"1982","journal-title":"Science"},{"key":"B216","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1073\/pnas.83.3.817","article-title":"Development and regional expression of beta nerve growth factor messenger RNA and protein in the rat central nervous system.","volume":"83","author":"Whittemore","year":"1986","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"B217","doi-asserted-by":"publisher","first-page":"9231","DOI":"10.1073\/pnas.83.23.9231","article-title":"Continuous infusion of nerve growth factor prevents basal forebrain neuronal death after fimbria fornix transection.","volume":"83","author":"Williams","year":"1986","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"B218","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1002\/ana.410410114","article-title":"Reversible Schwann cell hyperplasia and sprouting of sensory and sympathetic neurites after intraventricular administration of nerve growth factor.","volume":"41","author":"Winkler","year":"1997","journal-title":"Ann. Neurol."},{"key":"B219","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1038\/nrn3983","article-title":"A genetic cause of Alzheimer disease: mechanistic insights from Down syndrome.","volume":"16","author":"Wiseman","year":"2015","journal-title":"Nat. Rev. Neurosci."},{"key":"B220","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.jprot.2008.10.007","article-title":"The coming of age of axonal neurotrophin signaling endosomes.","volume":"72","author":"Wu","year":"2009","journal-title":"J. Proteomics"},{"key":"B221","doi-asserted-by":"publisher","first-page":"5406","DOI":"10.1523\/jneurosci.21-15-05406.2001","article-title":"Nerve growth factor activates persistent Rap1 signaling in endosomes.","volume":"21","author":"Wu","year":"2001","journal-title":"J. Neurosci."},{"key":"B222","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.02444","article-title":"Complete morphologies of basal forebrain cholinergic neurons in the mouse.","volume":"3","author":"Wu","year":"2014","journal-title":"eLife"},{"key":"B223","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/bf00304627","article-title":"Granulovacuolar degeneration in the hippocampal cortex of aging and demented patients\u2013a quantitative study.","volume":"85","author":"Xu","year":"1992","journal-title":"Acta Neuropathol."},{"key":"B224","doi-asserted-by":"publisher","first-page":"1815","DOI":"10.1172\/jci82409","article-title":"Amyloid precursor protein-mediated endocytic pathway disruption induces axonal dysfunction and neurodegeneration.","volume":"126","author":"Xu","year":"2016","journal-title":"J. Clin. Invest."},{"key":"B225","doi-asserted-by":"publisher","first-page":"7720","DOI":"10.1074\/jbc.m110929200","article-title":"Amyloid beta binds trimers as well as monomers of the 75-kDa neurotrophin receptor and activates receptor signaling.","volume":"277","author":"Yaar","year":"2002","journal-title":"J. Biol. Chem."},{"key":"B226","doi-asserted-by":"publisher","first-page":"2333","DOI":"10.1172\/jci119772","article-title":"Binding of beta-amyloid to the p75 neurotrophin receptor induces apoptosis. A possible mechanism for Alzheimer\u2019s disease.","volume":"100","author":"Yaar","year":"1997","journal-title":"J. Clin. Invest."},{"key":"B227","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.33012","article-title":"Multivesicular bodies mediate long-range retrograde NGF-TrkA signaling.","volume":"7","author":"Ye","year":"2018","journal-title":"eLife"},{"key":"B228","doi-asserted-by":"publisher","first-page":"7594","DOI":"10.1523\/jneurosci.17-20-07594.1997","article-title":"Absence of p75NTR causes increased basal forebrain cholinergic neuron size, choline acetyltransferase activity, and target innervation.","volume":"17","author":"Yeo","year":"1997","journal-title":"J. Neurosci."},{"key":"B229","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1038\/35052055","article-title":"Rab proteins as membrane organizers.","volume":"2","author":"Zerial","year":"2001","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"B230","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/s0306-4522(02)00404-9","article-title":"Amyloid beta peptide induces tau phosphorylation and loss of cholinergic neurons in rat primary septal cultures.","volume":"115","author":"Zheng","year":"2002","journal-title":"Neuroscience"},{"key":"B231","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1002\/clc.4960290313","article-title":"Otto Loewi and the chemical transmission of vagus stimulation in the heart.","volume":"29","author":"Zimmer","year":"2006","journal-title":"Clin. Cardiol."},{"key":"B232","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1038\/nrn1727","article-title":"Functions and mechanisms of retrograde neurotrophin signalling.","volume":"6","author":"Zweifel","year":"2005","journal-title":"Nat. Rev. Neurosci."}],"container-title":["Frontiers in Neuroscience"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fnins.2019.00446\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,12,10]],"date-time":"2020-12-10T15:50:37Z","timestamp":1607615437000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fnins.2019.00446\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5,7]]},"references-count":232,"alternative-id":["10.3389\/fnins.2019.00446"],"URL":"https:\/\/doi.org\/10.3389\/fnins.2019.00446","relation":{},"ISSN":["1662-453X"],"issn-type":[{"value":"1662-453X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,5,7]]},"article-number":"446"}}